FDA approval of Roche, Boehringer drugs for idiopathic pulmonary fibrosis is a big step forward The U.S. Food and Drug Administration has approved two drugs Esbriet and Ofev for the treatment of idiopathic pulmonary fibrosis (IPF). The drugs slow down the progression of the disease. by Sumit Passary
Healthy Living/Wellness Nintedanib, Pirfenidone cancer drugs give hope to patients battling idiopathic pulmonary fibrosis by Anne Francis